BIJAN AHRARI
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism LAS VEGAS, NV NPI 1679726467
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NV CHIESI USA, INC. All categories
General Payments — all program years on this page
$39,821.84
- Category: General Payments
- Program years: PY2018–2024
- Record count: 483
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,474.55 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,474.55 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| CHIESI USA, INC. | $381.82 | 5 |
| SANOFI-AVENTIS U.S. LLC | $332.51 | 10 |
| Abbott Laboratories | $304.81 | 10 |
| Novo Nordisk AS | $208.55 | 6 |
| RECORDATI_RARE_DISEASES_INC. | $189.76 | 3 |
| Corcept Therapeutics | $166.36 | 2 |
| Madrigal Pharmaceuticals | $141.46 | 2 |
| Tandem Diabetes Care, Inc. | $123.97 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $122.71 | 7 |
| Esperion Therapeutics, Inc. | $109.18 | 1 |
| ABBVIE INC. | $87.21 | 4 |
| Kyowa Kirin, Inc. | $52.89 | 2 |
| PFIZER INC. | $40.46 | 2 |
| Amgen Inc. | $37.10 | 2 |
| Lilly USA, LLC | $34.73 | 2 |
| Neurocrine BioSciences, Inc. | $24.84 | 1 |
| Lexicon Pharmaceuticals, Inc. | $23.37 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.86 | 1 |
| BETA BIONICS, INC. | $20.24 | 2 |
| MannKind Corporation | $17.75 | 1 |
| Endo Pharmaceuticals Inc. | $17.73 | 1 |
| IBSA Pharma Inc. | $14.24 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.